Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.85USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,789
52-wk High
$3.82
52-wk Low
$1.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.003
Jun '17 -0.003
Mar '17 -0.003
FY 2016 Dec '16 0.00 -0.003
Sep '16 -0.001
Jun '16 0.00 -0.002
Mar '16 -0.002
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.87 33.62
P/E High - Last 5 Yrs. 329.55 285.81 46.17
P/E Low - Last 5 Yrs. 329.55 93.64 24.19
Beta 0.16 0.81 0.81
Price to Sales (TTM) -- 137.83 8.35
Price to Book (MRQ) 0.26 20.52 5.22
Price to Tangible Book (MRQ) 2.81 28.04 6.44
Price to Cash Flow (TTM) -- 128.31 25.88
% Owned Institutions 4.41 11.86 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.23
Payout Ratio(TTM) -- 8.14 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 64.95 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 58.16 7.57
Sales - 5 Yr. Growth Rate -- 33.63 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 356.67 -94.99 16.24
EPS (TTM) vs TTM 1 Yr. Ago 52.06 -- --
EPS - 5 Yr. Growth Rate -- 46.89 11.55
Capital Spending - 5 Yr. Growth Rate 40.63 43.77 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 22.53 6.12 3.39
LT Debt to Equity (MRQ) -- 16.21 12.39
Total Debt to Equity (MRQ) -- 18.27 15.84
Interest Coverage (TTM) -- -156.52 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.30 54.79
Gross Margin - 5 Yr. Avg. -- 55.30 52.59
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -230.69 14.70
Operating Margin (TTM) -- -487.70 4.10
Operating Margin - 5 Yr. Avg. -- -247.29 9.99
Pre-Tax Margin (TTM) -- -463.92 4.83
Pre-Tax Margin - 5 Yr. Avg. -- -253.91 10.24
Net Profit Margin (TTM) -- -445.10 1.55
Net Profit Margin - 5 Yr. Avg. -- -257.36 6.54
Effective Tax Rate (TTM) -- 0.46 21.93
Effective Tax Rate - 5 Yr. Avg. -- 17.72 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,863,557 817,554,851
Net Income/Employee (TTM) -- -520,338 95,586,843
Receivable Turnover (TTM) -- 13.83 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -36.47 -1.04 10.73
Return on Assets - 5 Yr. Avg. -30.54 -0.14 12.03
Return on Investment (TTM) -37.45 -0.71 13.63
Return on Investment - 5 Yr. Avg. -39.11 2.18 15.76
Return on Equity (TTM) -53.30 -3.37 15.39
Return on Equity - 5 Yr. Avg. -32.85 -1.91 17.03
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 32.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for X T L Biopharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.41%
# of Holders: 5
Total Shares Held: 226,757
3 Mo. Net Change: 121,045
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.